The Molecular Mechanisms Contributing to the Specific Localization of HIV-1 Gag to the Plasma Membrane
HIV-1 Gag 特异性定位于质膜的分子机制
基本信息
- 批准号:9754564
- 负责人:
- 金额:$ 3.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2020-07-31
- 项目状态:已结题
- 来源:
- 关键词:Antiviral AgentsBindingBiological AssayBlood Coagulation Factor VIICapsidCell membraneCellsEnsureGenetic TranscriptionGoalsHIVHIV-1Higher Order Chromatin StructureImageryLiposomesLocationMediatingMediator of activation proteinMembraneMethodsModelingModificationMolecularMovementNucleocapsidOptimum PopulationsOutcome StudyPhasePhospholipidsPlayPopulationProcessPublishingRNARNA BindingResistance developmentRoleSiteSurfaceTestingTransfer RNATranslationsViralViral Structural ProteinsVirionVirusVirus AssemblyWorkcrosslinking and immunoprecipitation sequencingimprovedin vitro testingmolecular modelingparticlerecruittraffickingunilamellar vesicle
项目摘要
Project Summary/Abstract
HIV-1 Gag is a viral structural protein that mediates virus particle assembly at the
plasma membrane of infected cells. Gag trafficking to this site is a result of its interaction
with the plasma membrane specific phospholipid PI(4,5)P2. After membrane binding,
Gag multimerizes into higher order structures through the capsid and nucleocapsid
domains, which then drives the budding of new virus particles from the surface of the
host cell. Although the MA domain is capable of binding any acidic phospholipid, RNA
binding to MA inhibits the association of Gag with non-PI(4,5)P2-containing membranes.
Cellular tRNA has been shown to be the major RNA species that binds to the MA
domain of Gag. Notably, however, our published and preliminary results revealed that
some tRNAs are incapable of inhibiting Gag-membrane binding, whereas other tRNA
species inhibit Gag association with membranes even when they contain PI(4,5)P2.
Once Gag localizes to the plasma membrane, it is not known whether the presence of
PI(4,5)P2 is sufficient for the stable binding of Gag or whether Gag multimerization also
contributes to this stable association. Additionally, although we observed differences in
the abilities to bind the MA domain and to inhibit membrane binding of Gag among
different tRNA subsets, the molecular features of tRNA that are important for the optimal
inhibition of Gag membrane binding are still unclear. Defining the molecular interactions
that contribute to the stable membrane binding of Gag and binding of tRNA to the MA
domain are essential for understanding the processes that occur within infected cells to
drive the specific localization of Gag to the plasma membrane. Our central hypothesis is
that optimally inhibitory tRNA species become bound to the MA domain of Gag at the
site of translation, ensuring that Gag targets specifically to the plasma membrane where
PI(4,5)P2 and the multimerization of Gag promote stable membrane binding. In order to
test our hypothesis, we aim to identify the molecular interactions that contribute to the
binding and retention of Gag on the membrane (Aim 1) and to determine how and when
optimally inhibitory tRNA species become associated with the MA domain of Gag (Aim
2). The completion of this work will clarify the model for the molecular factors that are
important for the trafficking of Gag to the plasma membrane and its retention at this
location.
项目概要/摘要
HIV-1 Gag 是一种病毒结构蛋白,可介导病毒颗粒在
受感染细胞的质膜。对该网站的言论贩运是其互动的结果
具有质膜特异性磷脂 PI(4,5)P2。膜结合后,
Gag 通过衣壳和核衣壳多聚成更高阶的结构
域,然后驱动新病毒颗粒从表面萌芽
宿主细胞。尽管 MA 结构域能够结合任何酸性磷脂,但 RNA
与 MA 结合可抑制 Gag 与不含 PI(4,5)P2 的膜的结合。
细胞 tRNA 已被证明是与 MA 结合的主要 RNA 种类
加格的领域。然而值得注意的是,我们公布的初步结果表明
一些 tRNA 无法抑制 Gag 膜结合,而其他 tRNA
即使它们含有 PI(4,5)P2,物种也会抑制 Gag 与膜的结合。
一旦 Gag 定位于质膜,尚不清楚是否存在
PI(4,5)P2 足以稳定结合 Gag 或是否也发生 Gag 多聚化
为这种稳定的关联做出了贡献。此外,尽管我们观察到差异
结合 MA 结构域和抑制 Gag 膜结合的能力
不同的 tRNA 子集,tRNA 的分子特征对于最佳结果很重要
Gag 膜结合的抑制作用仍不清楚。定义分子相互作用
有助于 Gag 的稳定膜结合以及 tRNA 与 MA 的结合
域对于理解受感染细胞内发生的过程至关重要
驱动 Gag 特定定位到质膜。我们的中心假设是
最佳抑制性 tRNA 种类与 Gag 的 MA 结构域结合
翻译位点,确保 Gag 专门针对质膜
PI(4,5)P2 和 Gag 的多聚化促进稳定的膜结合。为了
检验我们的假设,我们的目标是确定有助于
Gag 在膜上的结合和保留(目标 1)并确定如何以及何时
最佳抑制性 tRNA 种类与 Gag 的 MA 结构域相关(目的
2)。这项工作的完成将阐明分子因素的模型
对于 Gag 向质膜的运输及其在质膜上的保留很重要
地点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher Aaron Sumner其他文献
Christopher Aaron Sumner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Continuing Grant
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Discovery Projects
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Fellowship
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Research Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Standard Grant
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Research Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Discovery Projects